Amanda Bastos Lira1, Célio Fernando de Sousa Rodrigues2. 1. Medical Sleep and ENT of Santa Casa Hospital, Professora Hígia Vasconcelos street, 193, Ponta verde, Maceió, Alagoas, 57035-140, Brazil. ablira@hotmail.com. 2. University of Alagoas/Brazil, Maceió, Alagoas, Brazil.
Abstract
PURPOSE: The hypoxia and reoxygenation cycles in obstructive sleep apnea syndrome (OSAS) cause a change in the oxidative balance, leading to the formation of reactive oxygen species capable of reacting with other organic molecules impairing their functions. This study aimed to determine the best markers of oxidative stress in OSAS and what better antioxidant agent to be used to treat the disease. METHODS: Searches were conducted in three different databases (PubMed, LILACS, SCIELO), using as descriptors the terms obstructive sleep apnea, oxidative stress, and antioxidant therapy. A total of 120 articles were found but only those considered of interest to the research were selected. Thus, 10 articles were included for further analysis regarding the biomarkers of oxidative stress in OSAS, and 6 articles to evaluate the antioxidant most often used for demonstration of efficacy. RESULTS: The thioredoxin, malondialdehyde, superoxide dysmutase, and reduced iron were the most commonly used biomarkers and showed a more consistent relationship between increased oxidative stress and OSAS. As antioxidant therapy, vitamin C and N-acetylcysteine (NAC) presented interesting results as a reduction of oxidative stress, which may become an alternative to the complementary treatment of OSAS. CONCLUSIONS: This review's findings agree mostly to measure that the markers of oxidative stress in OSAS may be a contributing aspect to assessment and monitoring of patient, and the antioxidant therapy appears to be beneficial in the treatment of OSAS.
PURPOSE: The hypoxia and reoxygenation cycles in obstructive sleep apnea syndrome (OSAS) cause a change in the oxidative balance, leading to the formation of reactive oxygen species capable of reacting with other organic molecules impairing their functions. This study aimed to determine the best markers of oxidative stress in OSAS and what better antioxidant agent to be used to treat the disease. METHODS: Searches were conducted in three different databases (PubMed, LILACS, SCIELO), using as descriptors the terms obstructive sleep apnea, oxidative stress, and antioxidant therapy. A total of 120 articles were found but only those considered of interest to the research were selected. Thus, 10 articles were included for further analysis regarding the biomarkers of oxidative stress in OSAS, and 6 articles to evaluate the antioxidant most often used for demonstration of efficacy. RESULTS: The thioredoxin, malondialdehyde, superoxide dysmutase, and reduced iron were the most commonly used biomarkers and showed a more consistent relationship between increased oxidative stress and OSAS. As antioxidant therapy, vitamin C and N-acetylcysteine (NAC) presented interesting results as a reduction of oxidative stress, which may become an alternative to the complementary treatment of OSAS. CONCLUSIONS: This review's findings agree mostly to measure that the markers of oxidative stress in OSAS may be a contributing aspect to assessment and monitoring of patient, and the antioxidant therapy appears to be beneficial in the treatment of OSAS.
Authors: W Jordan; S Cohrs; D Degner; A Meier; A Rodenbeck; G Mayer; J Pilz; E Rüther; J Kornhuber; S Bleich Journal: J Neural Transm (Vienna) Date: 2005-06-15 Impact factor: 3.575
Authors: Jianguo Li; Laura N Thorne; Naresh M Punjabi; Cheuk-Kwan Sun; Alan R Schwartz; Philip L Smith; Rafael L Marino; Annabelle Rodriguez; Walter C Hubbard; Christopher P O'Donnell; Vsevolod Y Polotsky Journal: Circ Res Date: 2005-08-25 Impact factor: 17.367
Authors: Jana Volná; David Kemlink; Marta Kalousová; Jana Vávrová; Veronika Majerová; Otto Mestek; Jana Svarcová; Karel Sonka; Tomás Zima Journal: Med Sci Monit Date: 2011-09
Authors: Jingjing Liang; Brian E Cade; Karen Y He; Heming Wang; Jiwon Lee; Tamar Sofer; Stephanie Williams; Ruitong Li; Han Chen; Daniel J Gottlieb; Daniel S Evans; Xiuqing Guo; Sina A Gharib; Lauren Hale; David R Hillman; Pamela L Lutsey; Sutapa Mukherjee; Heather M Ochs-Balcom; Lyle J Palmer; Jessica Rhodes; Shaun Purcell; Sanjay R Patel; Richa Saxena; Katie L Stone; Weihong Tang; Gregory J Tranah; Eric Boerwinkle; Xihong Lin; Yongmei Liu; Bruce M Psaty; Ramachandran S Vasan; Michael H Cho; Ani Manichaikul; Edwin K Silverman; R Graham Barr; Stephen S Rich; Jerome I Rotter; James G Wilson; Susan Redline; Xiaofeng Zhu Journal: Am J Hum Genet Date: 2019-10-24 Impact factor: 11.025